Glycerol kinase deficiency

WikiDoc Resources for Glycerol kinase deficiency
Articles
Most recent articles on Glycerol kinase deficiency Most cited articles on Glycerol kinase deficiency Review articles on Glycerol kinase deficiency Articles on Glycerol kinase deficiency in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Glycerol kinase deficiency Images of Glycerol kinase deficiency Photos of Glycerol kinase deficiency Podcasts & MP3s on Glycerol kinase deficiency Videos on Glycerol kinase deficiency
Evidence Based Medicine
Cochrane Collaboration on Glycerol kinase deficiency Bandolier on Glycerol kinase deficiency TRIP on Glycerol kinase deficiency
Clinical Trials
Ongoing Trials on Glycerol kinase deficiency at Clinical Trials.gov Trial results on Glycerol kinase deficiency Clinical Trials on Glycerol kinase deficiency at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Glycerol kinase deficiency NICE Guidance on Glycerol kinase deficiency NHS PRODIGY Guidance FDA on Glycerol kinase deficiency CDC on Glycerol kinase deficiency
Books
Books on Glycerol kinase deficiency
News
Glycerol kinase deficiency in the news Be alerted to news on Glycerol kinase deficiency News trends on Glycerol kinase deficiency
Commentary
Blogs on Glycerol kinase deficiency
Definitions
Definitions of Glycerol kinase deficiency
Patient Resources / Community
Patient resources on Glycerol kinase deficiency Discussion groups on Glycerol kinase deficiency Patient Handouts on Glycerol kinase deficiency Directions to Hospitals Treating Glycerol kinase deficiency Risk calculators and risk factors for Glycerol kinase deficiency
Healthcare Provider Resources
Symptoms of Glycerol kinase deficiency Causes & Risk Factors for Glycerol kinase deficiency Diagnostic studies for Glycerol kinase deficiency Treatment of Glycerol kinase deficiency
Continuing Medical Education (CME)
CME Programs on Glycerol kinase deficiency
International
Glycerol kinase deficiency en Espanol Glycerol kinase deficiency en Francais
Business
Glycerol kinase deficiency in the Marketplace Patents on Glycerol kinase deficiency
Experimental / Informatics
List of terms related to Glycerol kinase deficiency

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Raviteja Guddeti, M.B.B.S. [2]

Overview

Glycerol Kinase Deficiency (GKD) is an X-linked recessive enzyme defect that is heterozygous in nature. Three clinically distinct forms of this deficiency have been proposed, namely infantile, juvenile, and adult. National Institutes of Health and its Office of Rare Diseases Research (ORDR) branch classifies GKD as a rare disease, known to affect less than 200,000 individuals in the United States. The responsible gene lies in a region containing genes in which deletions can cause Duchenne muscular dystrophy and adrenal hypoplasia congenita. Combinations of these three genetic defects including GKD are addressed medically as Complex GKD.

Classification

GKD can be divided into three distinct forms: infantile, juvenile, and adult. Out of all of these the infantile form is the most clinically relevant because it leads to developmental delay and adrenal insufficiency.

• The infantile form is referred to as complex GKD because the defect in the gene for the glycerol kinase enzyme is interconnected with defects in one or both of its affected genes that are responsible for Duchenne muscular dystrophy and adrenal hypoplasia congenita.The cause of this form is deletion of the Xp21 gene on the X chromosome. Patients have increased levels of serum creatine phosphokinase(CPK) which leads to myopathic changes in muscle biopsies resembling Duchenne muscular dystrophy.
• The juvenile form does not show myopathy and patients have normal adrenal function.The main cause leading to this form of GKD is isolated enzyme deficiency.
• The adult form is also caused by an isolated enzyme deficiency. Patients having this form of the disorder are clinically normal.

Pathophysiology

To better understand how this condition affects a person a basic understanding of the process called glycolysis is important. The process provides energy for our cells to carry out their daily functions. The overall reaction involves a cell taking in the sugar glucose and converting it into the energy rich molecule pyruvate. The glucose first gathers a phosphate group from an ATP molecule in order to become glucose-6-phosphate. It is then changed into fructose 6-phosphate, with the assistance of phosphoglucose isomerase, which is then changed into fructose 1,6-biphosphate when the fructose molecule receives a phosphate group from another ATP. The next step in the chain is crucial for cells in order to make more energy than they expend through the process of glycolysis; this step is when the fructose 1,6-bisphosphate molecule breaks down into two molecules of dihydroxyacetone phosphate (DHAP), so from this point on whenever ATP is being generated from ADP there are really two ATP molecules generated because there are two molecules undergoing the same reaction. One molecule that takes advantage of this second part of the metabolic process is the fatty molecule glycerol. This is unfortunately prevented if someone is experiencing Glycerol Kinase Deficiency.

When a human’s body needs to use stored fat for energy it will release glycerol and other fatty acids into the bloodstream. However, these glycerol molecules must contribute to the process of glycolysis before they can provide energy to the body, as they do not hold the necessary energy within themselves. So before glycerol can enter the pathway of glycolysis it must be converted into an intermediate molecule, which in this case is dihydroxyacetone phosphate (DHAP). This is where glycerol kinase comes into the picture. The enzyme is used in the first step in turning glycerol into dihydroxyacetone phosphate (DHAP). It catalyzes the transfer of a phosphate group from an ATP to a glycerol molecule forming glycerol (3) phosphate. Then glycerol 3-phosphate, with the assistance of glycerol 3-phosphate dehydrogenase, can be dehydrogenated into DHAP. This molecule can then enter the metabolic pathway of glycloysis and provide more energy for the cell. Looking at the entire glycolysis pathway this conversion would yield an extra ATP for each glycerol molecule that eventually made its way into a DHAP molecule, which demonstrates the benefit of releasing glycerol into the bloodstream. However, when suffering from a glycerol kinase deficiency many of the glycerol molecules released into the bloodstream end up not being converted to dihydroxyacetone phosphate (DHAP), because the host does not have enough of the enzyme to catalyze all of the reactions waiting to occur. These extra molecules of glycerol are left floating around in the cell and can cause serious damage if left untreated.

Glycerol kinase deficiency causes the condition known as hyperglycerolemia, an accumulation of glycerol in the blood and urine. This excess of glycerol in bodily fluids can lead to many more potentially dangerous symptoms.

Genetics

Glycerol Kinase Deficiency has two main causes associated with it.

• The first cause is isolated enzyme deficiency. The enzyme glycerol kinase is encoded by the X-chromosome in humans. It acts as a catalyst in the phosphorylation of glycerol to glycerol-3-phosphate which plays a key role in formation of triacylglycerol (TAG) and fat storage. There is no genotype–phenotype correlation in isolated GKD and it can be either symptomatic or asymptomatic. Symptomatic means that GKD shows symptoms when it persists in the body and asymptomatic means that the no symptoms appear in the body. In this deficiency the genotype is not associated with the phenotype. The presence of certain mutations in genes has no relation with the phenotype i.e. any resulting physical traits or abnormality.
• The second cause is a deletion or mutation of a single gene. GKD is described by mendelian inheritance and is an X-linked recessive trait due to which it occurs mainly in males and occasionally in females. GKD results when the glycerol kinase gene present on the locus Xp21 of the X chromosome is either deleted or mutated. Females have two X chromosomes and males have one X and one Y chromosome .The expression of recessive genes on the X chromosome is different in males and females. This is due to the fact that genes present on the Y chromosome do not pair up with genes on the X chromosome in males. In females the disorder is expressed only when there are two copies of the affected gene present on each X chromosome but since the glycerol kinase gene is present only on one X chromosome the disorder is not expressed in women. Women have a second good copy that can compensate for the defect on the first copy. On the other hand males only need a single copy of the recessive gene for the disorder to be expressed. They do not have a second copy that can protect against any defect on the first copy.

Associated Disorders

• Duchenne Muscular Dystrophy
• Adrenal Hypoplasia Congenita
• Osteoporosis

Diagnosis

Symptoms

Common symptoms include

• Vomiting
• Lethargy. These tend to be the only symptoms, if any, present in adult GKD which has been found to present with fewer symptoms than infant or juvenile GKD. When GKD is accompanied by Duchenne Muscular Dystrophy and Adrenal Hypoplasia Congenita, also caused by mutations on the Xp21 chromosome, the symptoms can become much more severe.
• Seizures
• Learning disabilities
• Adrenal insufficiency
• Myopathy

Many of the physically visible symptoms, such as cryptorchidism, strabismus, learning disabilities, and myopathy, tend to have an added psychological effect on the subject due to the fact that they can set him or her apart from those without GKD.

Physical Examination

Eye

• Strabismus

Genitals

• Cryptorchidism

Neurologic

• Seizures.

Laboratory Findings

• Serum electrolytes - Metabolic acidosis

Treatment

Treatments for Glycerol Kinase Deficiency are targeted to treat the symptoms because there are no permanent treatments for this disease. The main way to treat these symptoms is by using corticosteroids, glucose infusion, or mineralocorticoids. Corticosteroids are steroid hormones that are naturally produced in the adrenal glands. These hormones regulate stress responses, carbohydrate metabolism, blood electrolyte levels, as well as other uses. The mineralocorticoids, such as aldosterone control many electrolyte levels and allow the kidneys to retain sodium. Glucose infusion is coupled with insulin infusion to monitor blood glucose levels and keep them stable. .

Due to the multitude of varying symptoms of this disease, there is no specific treatment that will cure this disease altogether. The symptoms can be treated with many different treatments and combinations of medicines to try to find the correct combination to offset the specific symptoms. Everyone with Glycerol Kinase Deficiency has varying degrees of symptoms and thereby requires different medicines to be used in combination to treat the symptoms; however, this disease is not curable and the symptoms can only be managed, not treated fully. .